Sanity Group, a Berlin based cannabis company, is dedicated to the medicinal and health use of cannabinoids. 

Sanity's operations span from medicinal cannabis to consumer health and tech. 
We believe that everyone deserves to live a healthy life and therefore develop and distribute innovative, cannabinoid-based pharmaceuticals and wellbeing products to patients and customers around Europe.

We are looking for partners with cultivation facilities around the world, that would like to expand their European footprint.

You can reach our Imprint (EN) here:
https://sanitygroup.com/imprint/

DE: Über diesen Link erreichen Sie unser Impressum:
https://sanitygroup.com/de/impressum/

Our Careerpage: https://career.sanitygroup.com

SOJE Capital

German Media Pool

Redalpine

Navy Capital

Casa Verde Capital

British American Tobacco

Alyssa Milano

Dennis Aogo

Klaas Heufer-Umlauf

Mario Götze

Stefanie Giesinger

SevenVentures

Sanity Group

#2023 is drawing to a close – another exciting year! 

Time to take a breath, recharge and to look forward to the coming year #2024, which will bring a new #cannabis law in Germany and hopefully even more! 

We wish everyone wonderful Xmas with the beloved and your families & a happy new year!

What a week! Grashaus Projects is officially launched – we just opened Europe‘s first legal cannabis dispensary in Allschwil in Switzerland!🇨🇭And it was a blast! 

All information in our press release here:
https://lnkd.in/dV_8cVDs

🏛️ Gestern fand die öffentliche Expertenanhörung zum Cannabisgesetz (CanG) im Gesundheitsausschuss des Deutschen Bundestages statt. Die Komplexität der Debatte wurde durch die große Bandbreite der eingeladenen Expert:innen abgebildet. Diese kamen aus Bereichen wie der Sucht- und Drogenforschung, Polizei, Justiz, Ärzteschaft, Patientenvertretung, Sozialarbeit, Völkerrecht und Industrie.

Was wurde deutlich?
👉 An vielen Stellen wirft der vorliegende Entwurf des CanG noch Fragen bei den Expert:innen auf, vor allem was die Durchsetzbarkeit von Abstandsregeln, die Regelung von Nutzhanf und die fehlenden Konzepte und Finanzierung von Präventionsmaßnahmen betrifft.
👉 Die Expert:innen sind sich einig, dass für eine Versorgungsverbesserung von Patient:innen mit Medizinalcannabis der Genehmigungsvorbehalt abgeschafft werden muss.
👉 Um den Schwarzmarkt nachhaltig zurückzudrängen, braucht es neben Cannabis Clubs und Eigenanbau auch die angekündigte Säule 2 mit wissenschaftlich-begleiteten Pilotprojekten. 

👣 Wie geht es jetzt weiter? Die Expertenanhörung dient den Mitgliedern des Gesundheitsausschusses als Grundlage für ihre weitere Beratung am Gesetzestext. Am Ende der Beratungen steht eine Beschlussempfehlung, die Änderungsvorschläge am Gesetz enthält und dann zur 2./3. Lesung in den Bundestag übergeht, wo über den Entwurf abgestimmt wird.

#Bundestag #Cannabis #Cannabisgesetz #CanG #Gesetzentwurf #Säule1 #CannabisClubs #Eigenanbau #Analyse

-----
🇬🇧 

🏛️ Yesterday, the public expert hearing on the Cannabis Act (CanG) took place in the Health Committee of the German Bundestag. The complexity of the debate was reflected by the wide range of experts invited. They came from areas such as addiction and drug research, the police, the judiciary, the medical profession, patient representatives, social work, international law and industry.

What became clear?
👉 In many areas, the current draft of the CanG still raises questions among the experts, especially with regard to the enforceability of distance rules, the regulation of industrial hemp and the lack of concepts and funding for prevention measures.
👉 The experts agree that the approval requirement for reimbursement must be abolished in order to improve the care of medical cannabis patients. 
👉 In addition to cannabis clubs and home cultivation, the announced pillar 2 with evidence-based pilot projects is also needed to push back the black market in the long term. 

👣 What happens now? The expert hearing serves the members of the Health Committee as a basis for their further deliberations on the draft law. At the end of the deliberations, there is a recommendation for a resolution that contains proposed amendments to the law and then passes to the 2nd/3rd reading in the Bundestag, where the draft is voted on.

#Bundestag #cannabis #cannabislaw #CanG #draftlaw #pillar1 #cannabisclubs #homegrow #analysis

𝐘𝐄𝐒 𝐖𝐄 𝐏𝐈𝐋𝐎𝐓 𝐏𝐑𝐎𝐉𝐄𝐂𝐓 𝐈𝐍 𝐂𝐀𝐍𝐍𝐀𝐁𝐈𝐒!

3 Jahre Vorbereitungszeit sind in unser wissenschaftliches Modellprojekt in der Schweiz geflossen und wir sind mehr als stolz, es nun endlich offen publizieren zu dürfen. In unseren Abgabestellen in Allschwil und Liestal (Basel-Landschaft) werden wir als Sanity Group in den nächsten Jahren gemeinsam mit Michael Schaub vom ISGF wissenschaftliche Daten als Entscheidungsgrundlage für eine mögliche Legalisierung in der Schweiz erheben - unser Fokus liegt dabei auf 'Harm Reduction' und ist mit knapp 4.000 möglichen Teilnehmern das derzeit größte, freigegebene Modellprojekt in der Schweiz.

Vielen Dank an unsere tollen Partner, die uns hier unterstützt haben wie z.B. Luc Richner von CANNAVIGIA, SwissExtract AG und viele viele mehr. Ganz besonders gilt der Dank aber dem Team 'Grashaus Projects' um Leonhard, Sebastian, Adele, Aline, Tim und vielen mehr, die das Projekt über Jahre hinweg gepusht haben.

Hopp Schwiiz ⛑ los geht's! Mehr Info hier: https://shorturl.at/ktxU7

🚀 We are thrilled to share some groundbreaking news with you today:

Sanity Group is proud to announce a significant milestone: Alongside our esteemed partner, the Swiss Institute for Addiction and Health Research (ISGF), we have received final approval to conduct a pioneering study on the controlled dispensing of recreational cannabis in the canton of Basel-Landschaft, Switzerland.🇨🇭

The aim is to learn more about the effects of controlled access to cannabis and thus provide a solid scientific basis for possible decisions on future cannabis regulation in Switzerland. The study, led by Prof. Dr. Michael Schaub, Scientific Director of the ISGF, will examine the regulated sale of cannabis for non-medical purposes.

In the upcoming weeks, we will open Europe's first legal cannabis dispensaries in Basel-Landschaft!

All details in today's press release:
🇩🇪 👉 https://lnkd.in/dUNBCDHR
🇬🇧 👉 https://lnkd.in/eJHmSR5n

Please welcome Grashaus Projects as our newest brand in the Sanity-verse! 🤗

🥦 Grünes Licht die Sanity Group im Zuge der schweizerischen Modellprojekte. 

✔ Die Sanity Group und das Schweizer Institut für Sucht- und Gesundheitsforschung (ISGF) haben vom Schweizer Bundesamt für Gesundheit (BAG) die finale Freigabe zur Durchführung eines Modellprojekts zur kontrollierten Abgabe von Cannabis zu Genusszwecken im nordwestschweizerischen Kanton Basel-Landschaft (Baselland) erhalten. Das vermeldet die Sanity Group in einer Pressemitteilung. 

💡 Ziel der wissenschaftlich begleiteten Untersuchung ist, mehr über die Auswirkungen eines kontrollierten Zugangs zu Cannabis zu erfahren und damit eine solide wissenschaftliche Grundlage für mögliche Entscheidungen über eine künftige Cannabis-Regulierung in der Schweiz zu schaffen. Die Studie unter dem Namen Grashaus Projects soll noch in diesem Jahr starten. 

⚡ Die Abgabe erfolgt zunächst über eine erste Verkaufsstelle in der Gemeinde Allschwil, ein weiterer Standort in Liestal soll in Kürze folgen. Damit entstehen im Kanton Basel-Landschaft die ersten legalen Cannabis-Shops in Europa. Die Sanity Group ist das einzige deutsche Unternehmen, das zur Teilnahme an den Schweizer Pilotprojekten berechtigt ist.

Die deutsche Bundesregierung schaut nun ganz genau auf die Studienergebnisse der Schweiz, um sich hier Ideen für die deutschen Modellversuche in der sogenannten Säule 2 der #Cannabis-#Legalisierung abzuschauen.

🌿🎉 Today, we're lighting up the candles to celebrate a remarkable milestone - the 5th anniversary of Sanity Group, a journey filled with growth, innovation, and unwavering commitment to bring cannabis back to the middle of society! 

🎂🌱 Over the past five years, we've embarked on a thrilling adventure in the world of cannabis. We've seen the industry evolve, break barriers, and shift perceptions. Throughout it all, our passion for harnessing the potential of this incredible plant has remained at the heart of what we do.

🚀 From day one, our mission has been to provide access to safe, high-quality cannabis products, and to destigmatize its use, promoting a holistic approach to health and happiness. We've seen lives transformed, stories of recovery, and countless smiles shared among our incredible community.

🙏 None of this would have been possible without the dedicated team behind Sanity Group. Your hard work, creativity, and unrelenting commitment to our mission have been the driving force behind our success. 🙌

📈 The past five years have been filled with groundbreaking achievements, innovative products, and partnerships that have taken us to new heights. But we're just getting started! As we look ahead, we're excited for the opportunities and challenges that the future holds, confident in our ability to continue leading the way in this ever-evolving industry.

💚 To our loyal customers, partners, and supporters, thank you for joining us on this incredible journey. Your trust and enthusiasm have been our greatest motivators.

🌿 Happy 5th Anniversary, Sanity Group! Here's to the next five years and beyond, as we work together to empower lives through cannabis. 🎉🌱 

#SanityGroup #Anniversary #CannabisCommunity #Cannabis #PowerToThePlant

🏛 Gestern fand im Bundestag die erste Lesung zum geplanten #Cannabisgesetz (Säule 1) statt. Bei den Stellungnahmen der Fraktionen gab es keine großen Überraschungen – während die Sprecher:innen der Ampelfraktionen den Gesetzentwurf als Paradigmenwechsel lobten, kritisierten die Sprecher:innen der Opposition den Entwurf als gefährlich für Jugend- & Gesundheitsschutz. 

Daneben wurden Verbesserungsvorschläge am Gesetzentwurf gefordert, u. a.:
- Mindestabstände für Anbauvereinigungen & Konsumabstände zu Kinder- & Jugendeinrichtungen sollten verändert/aufgehoben werden (SPD, Grüne, FDP, Linke)
- Konsumverbot in Clubs sollte aufgehoben werden (SPD, Grüne, FDP, Linke)
- Konsumverbot für Patient:innen sollte aufgehoben werden (FDP)
- Grenzwerte im Straßenverkehr sollten angepasst werden (SPD, Grüne, Linke)
- Obergrenzen für THC & Besitzmengenbegrenzung sollten aufgehoben werden (FDP)
- Stärkung der Therapiehoheit der Ärzteschaft (CDU/CSU)
- Anpassung des Genehmigungsvorbehalts (CDU/CSU)

👉 Im nächsten Schritt wird der Gesetzentwurf zur genaueren Prüfung und Bearbeitung an den zuständigen Ausschuss weitergeleitet. Dort findet i. d. R. auch eine Anhörung von Expert:innen statt. Für das CanG wird diese am 6.11.2023 im Gesundheitsausschuss stattfinden. Am Ende der Beratung in den Ausschüssen gibt es eine Beschlussempfehlung, die Änderungsvorschläge am Gesetz enthält. Die Beschlussempfehlung geht dann zur zweiten/dritten Lesung in den Bundestag, wo über den Entwurf abgestimmt wird.

--

🇬🇧 Yesterday, the Cannabis Law (CanG) was introduced in the German Bundestag. This so-called 1st reading as part of the parliamentary process includes a debate in which the spokespersons inside of the various parliamentary groups express their viewpoints on the necessity and goals of the proposed law. There were no major surprises in the statements of the parliamentary groups, but some meaningful improvement ideas to the bill:
- Minimum distances for cannabis clubs & consumption distances to children’s and youth facilities should be changed/removed (SPD, Greens, FDP, The Left).
- Ban on consumption in clubs should be lifted (SPD, Greens, FDP, The Left)
- Consumption ban for patients should be lifted (FDP)
- THC limits in road traffic should be adjusted (SPD, Greens, The Left)
- Upper limits for THC & Cannabis possession limits should be lifted (FDP)
- Strengthening of the medical profession’s therapeutic sovereignty (CDU/CSU)
- Adjustment of the authorisation requirement of the health insurance companies (CDU/CSU)

In the next step, the draft law will be forwarded to the Bundestag health committee for a more detailed examination and processing. A hearing of experts will be held there on November 6th, 2023. At the end of the deliberations in the committees, there will be a recommendation containing proposed amendments to the law. The recommended resolution then goes back to the Bundestag for a 2nd/3rd reading, where the draft is voted on (currently scheduled for Nov 16th).

We spoke with Sifted about the #cannabis #legalization plans in Germany and what they mean for businesses.

A little pictorial recap of this year’s Bits & Pretzels 2023 in Munich: One week ago, we had the opportunity to speak with our investor Klaas Heufer-Umlauf and moderator Janna Linke on stage about Sanity Group, the current #cannabis legalization, the opportunities for startups and why investing in cannabis and the #legalization are generally a good idea. A quick survey on the main stage showed that 95% of the audience agreed with the legalization. 
#letsdoit

Many thanks to the organizers for again a great event, and the opportunity to speak on stage! It was a blast!

Ann-Kathrin Kühnle, Felix Haas, Bernd Storm vans Gravesande, Andreas Etten, Andy Bruckschloegl, Flo Akinbiyi Janna Linke Finn Age Hänsel

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

WordPress

Font Awesome

LetsEncrypt

Marketing and Product

Agata Holcer

Human Resources

Anna Textor

Antonia Menzel

Business Management

Finn Age

Konstantin Rutz

Laura Simonow

Finn Age Haensel

Founder and Managing Director

Fabian Friede

Founder & Managing Director

Kevin Urbaum

Chief Of Staff

Roberto Boschiroli

Head Of Performance Marketing

Leonhard Friedrich

Laszlo S.

New Business & Strategy Manager

European Union (EU) Companies With More Than 10 Employees (Top 10K)

Health Care Companies With Fewer Than 1000 Employees (Top 10K)

Berlin Companies (Top 10K)

Wellness Companies With More Than 10 Employees (Top 10K)

Sanity Group is a European cannabis company focusing on health, wellbeing, and scientific research. The company's mission is to improve people’s quality of life through the use of cannabinoids, thus developing consumer products based on non-psychoactive cannabinoids.

It was founded in 2018 and is headquartered in Berlin, Germany.

OrganiGram

Convertible Note - Sanity Group

Secondary Market - Sanity Group

Series B - Sanity Group

Series A - Sanity Group

redalpine

Venture Round - Sanity Group

Calyx Bio-Ventures

HV Capital

Seed Round - Sanity Group

Berlin

Germany

Europe

Frankfurt And Hannover Prepare For Cannabis Sales Study Amid Health Alarms Over Black Market Contamination

Organigram invests 14 million euros in German cannabis operator Sanity Group

Organigram Invests in Sanity Group, a Leading German Cannabis Company

Organigram invests 14M euros in cannabis operator Sanity Group

Organigram takes stake in German cannabis firm Sanity Group with $21M investment

A pharmaceutical company developing and selling medicinal cannabis products to pharmacies and clinical institutions.

Provides personalized high-quality cannabis therapy products for patients.

A pilot project in Switzerland for the controlled distribution of recreational cannabis products.

Focuses on the development and production of finished pharmaceuticals.

Operates a cannabis extract production and processing facility near Frankfurt am Main.

Argentina

South America

Austria

United States

North America

Turkey

HTML5

Adobe Fonts

Google Analytics

HubSpot Marketing Hub

Vimeo

Google Maps API

Apache Server

Google Fonts

Office 365

A leading cannabis company with a diverse range of brands and a strong global presence.

Canopy Growth Corporation

A global cannabis company known for its high-quality, cost-efficient medical and adult-use cannabis products.

Aphria Inc.

A pioneering cannabis company with a diverse product line and a focus on medical cannabis research.

Tilray, Inc.

A globally diversified and vertically integrated cannabis company with a strong emphasis on research and development.

Cronos Group Inc.

A biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform.

GW Pharmaceuticals

Sanity Group is a holding company for various cannabis businesses in Europe, focused on unlocking the potential of cannabinoids to develop innovative cannabinoid-based pharmaceuticals and wellbeing products.

news impact assignment basic	general	Feb 21, 2024 3:15 PM	15841c08
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 21, 2024 3:15 PM	71ea450c
company summary	general
signals	general	Feb 21, 2024 3:15 PM	48a3677e
crunchbase trigger	general	Nov 22, 2024 7:44 AM	2876a0d9
crunchbase profile	general	Nov 22, 2024 8:49 AM	ac2c1d88
li profile	general	Feb 21, 2024 3:15 PM	67f67b1b
translate crunchbase fundingrounds	general	Nov 22, 2024 10:54 AM	30596ff4
peers	general	Feb 21, 2024 3:15 PM	b9b57683
news basic	general	Feb 21, 2024 3:15 PM	2e772369
bundesanzeiger	filings	Feb 21, 2024 3:15 PM	f93f8986
financials download nd	financials
private financials	financials

COM:SANITYGROUP

Sanity Group